Trials / Completed
CompletedNCT03416868
Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback
Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback in Small Groups of Patients With Vocal Hyperfunction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Patients with vocal hyperfunction will undergo standard of care voice therapy with ambulatory voice monitoring before therapy and after the first 3 voice therapy sessions. Biofeedback will be added to ambulatory monitoring after the 2nd voice therapy session only.
Detailed description
This study will use a single subject design to determine if adding ambulatory voice biofeedback to conventional voice therapy can result in faster carryover (generalization) of new vocal behaviors established during voice therapy to daily life. Here, ambulatory voice biofeedback will be based on objective measures that have subject-specific sensitivity to vocal hyperfunction. Hypothesis: The ambulatory voice biofeedback week (week 2) will result in higher generalization percentages when compared to baseline and the week prior to the initiation of biofeedback (week 1). This effect will be retained when the biofeedback is removed (week 3), thus it will be different than baseline and week 1, but not different than week 2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Ambulatory voice biofeedback | Patients will be provided cues regarding their vocal behavior in daily life. Specifically, the patient will receive 100% feedback = a vibrotactile cue on a smartwatch every time the patient voices incorrectly. The specific objective voice measure for biofeedback will depend upon which measure is most strongly associated with improvements during voice therapy. |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2024-01-25
- Completion
- 2024-02-05
- First posted
- 2018-01-31
- Last updated
- 2024-04-17
- Results posted
- 2024-04-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03416868. Inclusion in this directory is not an endorsement.